Clinical Trials Browser

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

NCT05088798 2025-12-19

18FDOPA HI

Phase 2 Recruiting

100 enrolled

Endocrine

Hyperinsulinism, Hypoglycemia, Infant, Newborn, Diseases, Insulinoma, Glucose Metabolism Disorders

NCT05686590 2024-12-16

Prehospital Provider Training With Augmented Reality (AR)

Phase NA Completed

22 enrolled

LymphoidOther hematologic neoplasm

Hypoglycemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02021604 2024-07-16

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

Phase 1 Recruiting

250 enrolled

Endocrine

Hyperinsulinism, Hypoglycemia, Insulinoma, Congenital Hyperinsulinism

NCT04452396 2023-12-12

CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia

Phase NA Terminated

7 enrolled

Endocrine

Hypoglycemia, Insulin Resistance, Insulinoma

NCT05308095 2022-12-21

The HEADWIND Study - Part 4

Phase NA Completed

10 enrolled

Diabetes Mellitus, Diabetes Mellitus, Type 1, Hypoglycemia, Carney Complex

NCT02779257 2022-03-04

Pasireotide Treatment for Neuroendocrine Tumor

Phase 4 Withdrawn

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Hypoglycemia

NCT00970541 2021-08-25

Eccentric

Phase 1 Terminated

8 enrolled

Hypoglycemia, Insulin Resistance, Polycystic Ovary Syndrome

NCT04569630 2021-06-29

HEADWIND

Phase NA Completed

22 enrolled

Diabetes Mellitus, Diabetes Mellitus, Type 1, Hypoglycemia, Carney Complex

Clinical Trials

Tumor HI

18FDOPA HI

Prehospital Provider Training With Augmented Reality (AR)

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia

The HEADWIND Study - Part 4

Pasireotide Treatment for Neuroendocrine Tumor

Eccentric

HEADWIND